Rare diseases
Investigational molecules
Locations
Back to Czechia46 clinical trials in Slany, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
CzechiaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
CzechiaStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
CzechiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
CzechiaStudy of SAR442970 to treat moderate to severe ulcerative colitis in adults
CzechiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
CzechiaStudy of vicadrostat and empagliflozin given together or separately in people with chronic kidney disease to test safety and effectiveness
CzechiaStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis
CzechiaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy on the Long-Term Safety and Effectiveness of Ozanimod for Adults with Moderate to Severe Ulcerative Colitis
CzechiaStudy on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis
CzechiaStudy on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on cardiovascular diseases and treatments, including trials for stroke prevention and heart conditions. Research encompasses new therapies for patients with atrial fibrillation and acute coronary syndrome.
Multiple trials evaluating novel anticoagulants and comparing their effectiveness to existing treatments.
Comprehensive research into inflammatory bowel conditions, with particular focus on ulcerative colitis and Crohn's disease. Studies evaluate new therapeutic approaches for moderate to severe cases.
Several trials testing innovative biological therapies and maintenance treatments for gastroenterological conditions.
Advanced research targeting metabolic conditions, including hypertriglyceridemia and cholesterol management. Studies focus on developing treatments for various lipid disorders.
Trials evaluating new medications for improving lipid profiles and reducing cardiovascular risk factors.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
